Turn Therapeutics (TTRX) Current Leases (2024 - 2026)

Turn Therapeutics' Current Leases history runs 3 years deep, the most recent figure standing at $47795.0 for Q1 2026.

• On a quarterly basis, Current Leases changed N/A year-over-year to $47795.0 in Q1 2026; TTM through Mar 2026 was $47795.0, a N/A change from a year earlier, with the FY2025 full-year figure at $46295.0, up 13.86% from the prior year.
• Current Leases improved to $47795.0 in Q1 2026 per TTRX's latest filing, from $46295.0 in the prior quarter.
• Across five years, Current Leases topped out at $47795.0 in Q1 2026 and bottomed at $40660.0 in Q4 2024.
• The 3-year median for Current Leases is $45562.0 (2025), against an average of $44894.8.
• Biggest YoY gain for Current Leases was 13.86% in 2025; the steepest drop was 13.86% in 2025.
• Year by year, Current Leases stood at $40660.0 in 2024, then grew by 13.86% to $46295.0 in 2025, then climbed by 3.24% to $47795.0 in 2026.
• Per Business Quant, the three latest TTRX Current Leases figures stand at $47795.0 (Q1 2026), $46295.0 (Q4 2025), and $44829.0 (Q3 2025).